Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.45 (1.80%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 25.50
REVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adam Minto Settlement Agreement

5 Feb 2024 07:00

RNS Number : 9368B
Revolution Beauty Group PLC
05 February 2024
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For immediate release

5 February 2024

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

Adam Minto Settlement Agreement

Further to the announcement of 13 December 2023, Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, is pleased to announce that it has reached a settlement agreement with Adam Minto, the Group's co-founder and former Chief Executive Officer ("CEO").

On 2 February 2024, Revolution Beauty and Adam Minto entered into a settlement agreement (the "Settlement Agreement") relating to the previously announced events that led to the delay of the audit of Revolution Beauty's FY22 results and the suspension of trading of the Group's shares on AIM during Adam Minto's time as CEO, with no admission or acceptance of liability by either party.

Pursuant to the Settlement Agreement, Revolution Beauty and Adam Minto have agreed to the full and final settlement of certain claims between them. In connection with this settlement, Adam Minto will pay Revolution Beauty a settlement sum of £2.9 million (the "Settlement Sum"). The Settlement Sum will be paid in six annual instalments, with the first payment of £483,333.35 due on 28 March 2024 and subsequent equal instalments of £483,333.33 due on 28 March of each calendar year (with the final instalment payable on 28 March 2029). If a Settlement Sum instalment is not paid on time, then interest will be charged at 8% per annum.

Having considered its options and legal advice received, the Board of Directors believe this is a fair settlement for the Company.

Alistair McGeorge, Non-Executive Chairman, commented: "We are very pleased to have reached an agreement with Adam. This, together with the revised payment schedule agreed in December 2023 for the acquisition of Medichem, means we can now focus on the future. We look forward to providing an update on our strategy at our upcoming Capital Markets Event on 8 February 2024".

The signing of the Settlement Agreement constitutes a related party transaction under Rule 13 of the AIM Rules for Companies (the "AIM Rules"), by virtue of Adam Minto being a substantial shareholder, as defined in the AIM Rules, of Revolution Beauty, holding approximately 15.34% of the ordinary shares in Revolution Beauty. The directors of Revolution Beauty consider, having consulted with Revolution Beauty's nominated adviser, Liberum Capital Limited, that the terms of this related party transaction are fair and reasonable insofar as shareholders of Revolution Beauty are concerned.

For further information, please contact:

 

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Liberum (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

 

Zeus: Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

Media enquiries

Headland Consultancy: Matt Denham / Will Smith / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

The person responsible for arranging the release of this announcement on behalf of the Company is Lauren Brindley, the Chief Executive Officer of the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRQKBBKDBKBNBK
Date   Source Headline
17th Jun 20247:00 amRNSNotice of FY24 Results
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application
24th Jan 20247:00 amRNSNotice of Capital Markets Event
13th Dec 20237:00 amRNSDirectorate changes and settlement agreement
8th Dec 20237:00 amRNSChange of Adviser & Rule 17 Schedule Two(g) Update
27th Nov 20237:00 amRNSPress speculation
22nd Nov 20237:18 amRNSHolding(s) in Company
14th Nov 20231:29 pmRNSHolding(s) in Company
14th Nov 20231:25 pmRNSHolding(s) in Company
14th Nov 20231:23 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSInterim Results
9th Nov 20231:21 pmRNSNotice of Interim Results
31st Oct 20236:08 pmRNSHolding(s) in Company
31st Oct 20236:07 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSResults of AGM
19th Sep 20237:00 amRNSGrant of Share Options
13th Sep 20232:44 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of AGM and posting of Annual Report
4th Sep 20235:30 pmRNSHolding(s) in Company
4th Sep 20235:27 pmRNSHolding(s) in Company
31st Aug 20238:32 amRNSDirectorate Changes
31st Aug 20238:30 amRNSFINAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2023
21st Aug 20237:00 amRNSNotice of Results
7th Aug 202312:45 pmRNSGeneral Meeting Indefinitely Adjourned
24th Jul 20234:22 pmRNSHolding(s) in Company
21st Jul 20234:57 pmRNSRegulatory Investigation
21st Jul 20231:43 pmRNSPDMR Dealing
21st Jul 202310:58 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSWithdrawal of GM requisition & Board Updates
18th Jul 20237:00 amRNSSettlement Agreement with boohoo
10th Jul 20234:49 pmRNSNotice of General Meeting
5th Jul 202310:37 amRNSChange of registered office address
4th Jul 20232:09 pmRNSDirector dealings
3rd Jul 20234:30 pmRNSDirector dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.